FOR IMMEDIATE RELEASE
n
Published on August 25th, 2026nin News
n
Washington D.C. – A landmark call for a National Plan for Epilepsy, designed to fundamentally transform care, research, and public awareness for the 3.4 million Americans living with the condition, has been officially published in the prestigious journal Epilepsy Currents. The comprehensive article, titled "Towards a National Plan for Epilepsy: A Unified Framework for Research, Care, and Awareness," lays out a strategic roadmap developed through an unprecedented collaboration of leading epilepsy organizations. This publication marks a pivotal moment, providing a robust framework to address the significant gaps that have long hindered progress in the fight against epilepsy.
n
Epilepsy Alliance America, a driving force behind this initiative, proudly announced the publication, emphasizing its potential to galvanize coordinated action nationwide. The article meticulously details the urgent need for a unified approach, underscoring how fragmented efforts have historically resulted in inconsistent patient outcomes, underfunded research, and persistent societal misunderstanding of the condition. The proposed National Plan champions a holistic strategy, integrating advancements in clinical care with targeted research investments and widespread public education campaigns.
n
"This publication in Epilepsy Currents is more than just an academic paper; it’s a declaration of intent, a blueprint for a healthier, more understanding future for individuals with epilepsy," stated a spokesperson for Epilepsy Alliance America. "For too long, the epilepsy community has navigated a landscape marked by disparities and a lack of cohesive national strategy. This plan, forged through the collective wisdom and unwavering dedication of numerous partners, offers a clear path forward."
n
Special recognition was given to Epilepsy Alliance America Board members Amanda Mitchell, MPH, LCCE, and Joyce Bender, whose tireless advocacy and expertise were instrumental in shaping the plan. Their contributions, alongside the broad coalition of partners, underscore the collaborative spirit essential for such an ambitious endeavor.
n
The coalition behind this groundbreaking effort includes an impressive roster of organizations: CURE Epilepsy, American Epilepsy Society, Epilepsies Action Network, Epilepsy Foundation, National Association of Epilepsy Centers (NAEC), Rare Epilepsy Network (REN), International League for Epilepsy, and The Epilepsy Leadership Council. This diverse group represents the full spectrum of the epilepsy community – from research and clinical care to patient advocacy and rare disease support – ensuring that the National Plan is comprehensive, inclusive, and actionable.
n
Further information, including detailed consensus priorities and a growing list of endorsing organizations from both within and outside the epilepsy community, is available at https://www.epilepsy-national-plan.org/consensus-priorities. The collaborative is actively encouraging broader engagement, believing that the success of the National Plan hinges on widespread support and commitment from all stakeholders.
n
Chronology: The Road to a Unified National Plan
n
The journey towards a comprehensive National Plan for Epilepsy has been a long and arduous one, marked by years of dedicated advocacy, increasing awareness of systemic gaps, and a growing consensus within the epilepsy community that a fragmented approach was no longer sustainable.
n
The Genesis of the Idea
n
The seeds of a national plan were sown over a decade ago, as leaders within various epilepsy organizations began to observe persistent and widening disparities in patient care, research funding, and public understanding. While individual organizations achieved significant milestones in their respective areas – CURE Epilepsy in funding innovative research, the Epilepsy Foundation in patient support and advocacy, the American Epilepsy Society in professional education – the overall impact felt disparate and often reactive rather than proactive. Conferences and informal discussions among leaders frequently circled back to a central theme: the lack of a unified national strategy meant that the collective impact was less than the sum of its parts. The idea gained significant traction following several high-profile reports in the early 2020s that highlighted the economic and social burden of epilepsy, starkly comparing it to other neurological conditions that had benefited from coordinated national efforts. These reports served as a powerful catalyst, moving the conversation from theoretical possibility to urgent necessity.
n
Formation of the Coalition
n
Recognizing the immense challenge and the critical need for a united front, the Epilepsy Leadership Council, an existing body dedicated to fostering collaboration among key epilepsy organizations, took the lead in mid-2023. They convened an initial summit, bringing together the heads of the major U.S. epilepsy organizations. The atmosphere was one of shared purpose and collective frustration with the status quo. Early meetings focused on identifying common goals and overcoming historical organizational silos. A core working group was established, comprising representatives from Epilepsy Alliance America, CURE Epilepsy, the American Epilepsy Society, and the Epilepsy Foundation. This group was tasked with drafting an initial concept paper outlining the scope and objectives of a potential National Plan. Amanda Mitchell and Joyce Bender of Epilepsy Alliance America were central figures in these early deliberations, bringing invaluable insights from both public health and patient advocacy perspectives. Their ability to bridge different viewpoints and articulate a compelling vision proved crucial in forging early consensus.
n
Developing the Framework
n
The development of the National Plan’s framework was an intensive, multi-phase process spanning over two years. It involved extensive stakeholder consultations, expert workshops, and iterative drafting cycles. In late 2024, a series of specialized task forces were formed, each focusing on a critical pillar of the plan: Research & Innovation, Clinical Care & Access, Public Awareness & Education, and Policy & Advocacy. These task forces included neurologists, researchers, public health experts, policymakers, persons with epilepsy, and caregivers. The process was meticulously consensus-driven, with every recommendation debated and refined to ensure broad support and practical applicability. White papers were commissioned on specific topics, data analyses were performed to quantify existing gaps, and international models of coordinated disease management were studied. The Rare Epilepsy Network (REN) and the National Association of Epilepsy Centers (NAEC) provided crucial input on specialized care needs and the unique challenges faced by specific patient populations, ensuring the plan was truly inclusive. By early 2026, a comprehensive draft was ready for final review by the broader coalition and endorsing organizations. The International League for Epilepsy also contributed, offering a global perspective and insights into best practices from other countries.
n
The Publication Milestone
n
The decision to publish the National Plan in Epilepsy Currents was strategic. As a peer-reviewed journal dedicated to clinical and basic science developments in epilepsy, it provided the ideal platform to formally introduce the plan to the scientific and medical communities, lending it academic credibility and facilitating its integration into professional discourse. The August 25th, 2026 publication date represents the culmination of years of tireless effort and marks a formal public unveiling of the collaborative’s vision. This article is not merely a summary of the plan; it is a detailed exposition of its rationale, core components, and anticipated impact. Its publication is intended to serve as a rallying cry, inviting broader engagement from government agencies, philanthropic organizations, healthcare providers, and the general public, signaling that the time for a coordinated national response to epilepsy has finally arrived.
n
Supporting Data: The Urgent Case for a National Plan
n
The necessity of a National Plan for Epilepsy is underscored by a wealth of compelling data that highlights the immense burden of the condition and the systemic deficiencies in current approaches. These statistics paint a stark picture, revealing not only the human cost but also the significant economic drain associated with fragmented care and insufficient investment.
n
The Scope of Epilepsy
n
Epilepsy is one of the most common serious neurological disorders globally, affecting approximately 50 million people worldwide. In the United States alone, 3.4 million individuals live with active epilepsy, meaning they have had at least one seizure in the past year or are currently taking medication to prevent seizures. This makes it more prevalent than Parkinson’s disease, multiple sclerosis, and cerebral palsy combined. Each year, an estimated 150,000 new cases are diagnosed in the U.S. While often associated with childhood, epilepsy can develop at any age, with incidence peaking in early childhood and late adulthood. The impact extends beyond seizures, encompassing a range of comorbidities such as depression, anxiety, cognitive impairment, and increased risk of Sudden Unexpected Death in Epilepsy (SUDEP), which claims over 3,000 lives annually in the U.S.
n
The economic burden of epilepsy is staggering. Direct medical costs, including emergency room visits, hospitalizations, physician fees, and medication, are estimated to exceed $15 billion annually in the U.S. When indirect costs are factored in – such as lost wages due to unemployment or underemployment, decreased productivity, caregiver burden, and disability benefits – the total societal cost is projected to surpass $30 billion per year. These figures do not fully capture the profound impact on quality of life, including social stigma, limitations on daily activities, driving restrictions, and educational and career challenges that many individuals with epilepsy face.
n
Gaps in Current System
n
Despite its prevalence and significant impact, epilepsy has historically suffered from disproportionately low research funding compared to other neurological conditions. For example, per-patient federal research funding for epilepsy has consistently lagged behind conditions like Alzheimer’s disease, Parkinson’s disease, and even less prevalent conditions, by a factor of two to five. This disparity directly impedes the discovery of new therapies, diagnostic tools, and prevention strategies.
n
Public awareness also remains critically low, leading to widespread misconceptions and stigma. Many people still associate epilepsy with outdated stereotypes, leading to discrimination in employment, education, and social settings. This lack of understanding contributes to diagnostic delays, with many individuals waiting years for an accurate diagnosis and appropriate treatment.
n
Access to optimal care is another critical challenge. Approximately one-third of individuals with epilepsy live with drug-resistant epilepsy, meaning their seizures are not controlled by available medications. For these patients, specialized care, including epilepsy surgery, dietary therapies, or neurostimulation, can be life-changing. However, access to the 250 National Association of Epilepsy Centers (NAEC) accredited facilities, which provide such comprehensive care, is unevenly distributed, with significant disparities in rural areas and underserved communities. Many patients lack geographical access, adequate insurance coverage, or awareness of these specialized options. The shortage of epileptologists (neurologists specializing in epilepsy) further exacerbates this access issue.
n
Evidence for Coordinated Action
n
The success of coordinated national plans in other disease areas provides compelling evidence for the potential impact of a similar approach for epilepsy. The National Cancer Act of 1971 transformed cancer research and care, leading to dramatic improvements in survival rates and quality of life. Similarly, the coordinated national response to HIV/AIDS significantly accelerated drug development, improved patient access to care, and reduced stigma. These models demonstrate that a unified strategy, with clear objectives, dedicated funding streams, and collaborative partnerships, can overcome complex public health challenges.
A national plan for epilepsy can leverage the collective strength of advocacy groups, research institutions, healthcare providers, and government agencies to:
- Strategically Prioritize Research: Direct funding towards high-impact areas, fostering collaboration and reducing redundant efforts.
- Standardize Care Pathways: Develop and disseminate evidence-based guidelines to ensure consistent, high-quality care nationwide.
- Amplify Public Awareness: Launch coordinated campaigns to combat stigma and improve understanding.
- Strengthen Workforce Development: Address shortages of specialized healthcare professionals.
- Influence Policy: Advocate for legislative changes that support patients and research.
By addressing these issues through a coordinated national effort, the National Plan for Epilepsy aims to significantly improve outcomes for millions of Americans, reducing the human suffering and economic burden associated with this often-misunderstood condition.
Official Responses: A United Front for Change
The unveiling of the National Plan for Epilepsy in Epilepsy Currents has been met with widespread enthusiasm and a strong commitment from the leadership of Epilepsy Alliance America and its partner organizations, signaling a united front dedicated to transforming the landscape of epilepsy care and research.
Statements from Epilepsy Alliance America Leadership
"This National Plan represents a monumental step forward for our community," declared Amanda Mitchell, MPH, LCCE, a prominent Board member of Epilepsy Alliance America and a key architect of the plan. "For years, we’ve advocated for a more cohesive, impactful approach. This publication is the culmination of immense dedication, bringing together the brightest minds and most passionate advocates. My hope is that this plan will serve as a powerful catalyst for policy changes, increased funding, and a fundamental shift in how epilepsy is understood and treated in America." Mitchell emphasized the importance of a patient-centered approach, ensuring that the voices and experiences of those living with epilepsy remain at the heart of every initiative derived from the plan.
Joyce Bender, another influential Board member and tireless advocate, echoed this sentiment, highlighting the personal significance of the plan. "Having lived with epilepsy myself, I understand the profound challenges, the stigma, and the daily struggles faced by millions," Bender stated passionately. "This National Plan is about more than just medical advancements; it’s about dignity, opportunity, and ensuring that no one with epilepsy feels isolated or underserved. It’s about breaking down barriers to employment, education, and full participation in society. We have a moral imperative to make this plan a reality." Her focus on societal integration and economic empowerment reflects a broader vision for comprehensive patient well-being.
Perspectives from Partner Organizations
Leaders from the collaborative organizations have universally embraced the National Plan, each articulating their specific commitment to its success:
- CURE Epilepsy: "Our mission at CURE Epilepsy is to find a cure for epilepsy by funding innovative research," commented a spokesperson. "The National Plan provides a crucial framework to strategically direct research investments, foster inter-institutional collaboration, and accelerate the translation of scientific discoveries into clinical practice. We believe this coordinated approach will significantly speed up the timeline for breakthrough therapies and ultimately, a cure."
- American Epilepsy Society (AES): "The AES is committed to advancing epilepsy care through professional education, research, and advocacy," stated the President of AES. "The National Plan offers a blueprint for standardizing clinical guidelines, expanding educational opportunities for healthcare professionals, and ensuring that all patients have access to the highest quality, evidence-based care. We look forward to working within this framework to elevate the practice of epileptology."
- Epilepsy Foundation: "For decades, the Epilepsy Foundation has been a beacon of support and advocacy for those impacted by epilepsy," shared the CEO. "This National Plan amplifies our collective voice, enabling us to launch more impactful public awareness campaigns, reduce stigma, and advocate more effectively for policies that prioritize the needs of individuals with epilepsy and their families. It’s a game-changer for patient empowerment and support services."
- National Association of Epilepsy Centers (NAEC): "As providers of specialized, comprehensive epilepsy care, NAEC recognizes the critical need to improve access to advanced treatments," noted an NAEC representative. "The National Plan’s focus on addressing geographic disparities and strengthening the network of specialized centers is vital. We are committed to collaborating to ensure that every patient, regardless of their location, can access the expert care they need, especially for complex and drug-resistant epilepsies."
- Rare Epilepsy Network (REN): "The challenges faced by individuals with rare epilepsies are often compounded by lack of awareness and specific research," said a REN leader. "The inclusive nature of the National Plan, which specifically addresses the unique needs of rare disease communities, is incredibly important. It promises to catalyze research into rare conditions and ensure that these often-overlooked populations receive equitable attention and resources."
- International League for Epilepsy (ILE): "Epilepsy is a global health challenge, and lessons learned internationally can inform national strategies," commented an ILE representative. "The ILE commends the U.S. collaborative for developing such a comprehensive plan. We are eager to share best practices and collaborate on initiatives that can have a worldwide impact, underscoring the interconnectedness of our global epilepsy community."
Government and Policy Maker Reactions
Initial reactions from government and policy circles have been cautiously optimistic and largely receptive. Congressional staffers familiar with healthcare policy have indicated a willingness to engage with the coalition to explore legislative avenues for implementing key aspects of the plan. Representatives from the National Institutes of Health (NIH) have acknowledged the comprehensive nature of the plan and its potential to inform future funding priorities and inter-agency collaborations. While full governmental endorsement and funding will require sustained advocacy, the robust, consensus-driven nature of the plan has provided a strong foundation for future policy discussions. The coalition plans to aggressively lobby for the inclusion of specific elements of the National Plan in upcoming federal health appropriations and legislative initiatives, viewing this initial reception as an encouraging first step towards securing the necessary governmental support.
Implications: A Future Transformed by Unified Action
The publication of the National Plan for Epilepsy is not merely an academic exercise; it represents a profound turning point with far-reaching implications for every individual touched by epilepsy. Its successful implementation promises a future where epilepsy is better understood, more effectively treated, and less stigmatized.
Potential Impact on Patients
For the millions of Americans living with epilepsy, the National Plan offers the promise of a dramatically improved quality of life. One of the most immediate impacts is anticipated to be in improved diagnosis and treatment pathways. By establishing national guidelines and promoting best practices, the plan aims to reduce diagnostic delays, ensure timely access to appropriate anti-seizure medications, and facilitate referrals to specialized epilepsy centers for those with drug-resistant forms of the condition. Patients can expect greater consistency in care, regardless of their geographic location or socioeconomic status.
Furthermore, the plan’s emphasis on enhanced quality of life extends beyond medical treatment. It addresses critical areas such as mental health support, vocational rehabilitation, and educational accommodations. By advocating for integrated care models that consider the whole person, the plan aims to reduce the burden of comorbidities like depression and anxiety, empower individuals to achieve their full potential in academic and professional settings, and provide robust support systems for caregivers who often bear significant responsibilities.
Crucially, the intensified focus on reduced stigma through widespread public awareness campaigns will be transformative. By dispelling myths and fostering a more informed society, the plan seeks to create an environment where individuals with epilepsy feel more accepted, less discriminated against, and empowered to openly discuss their condition without fear of judgment. This cultural shift could unlock new opportunities in employment and social engagement, significantly improving psychological well-being.
Impact on Research
The National Plan is poised to revolutionize epilepsy research by fostering a more strategic, collaborative, and impactful approach. Its framework calls for strategic funding priorities, directing resources towards areas of greatest need and potential for breakthrough, such as understanding epileptogenesis (how epilepsy develops), developing non-invasive diagnostic tools, discovering new therapeutic targets for drug-resistant epilepsy, and investigating SUDEP prevention strategies.
By promoting collaborative research initiatives, the plan aims to break down institutional silos, encouraging data sharing, multi-center trials, and interdisciplinary partnerships. This synergy will accelerate the pace of discovery, allowing researchers to leverage diverse expertise and resources more effectively. The goal is to achieve faster translation of discoveries into clinical practice, ensuring that cutting-edge research quickly benefits patients in real-world settings. This will involve streamlining regulatory processes where possible and fostering strong partnerships between academia, industry, and patient advocacy groups.
Moreover, the plan will focus on neglected areas of research. This includes dedicated efforts to understand and prevent SUDEP, address the complex interplay of epilepsy with mental health conditions, and develop tailored treatments for rare and genetic epilepsies, ensuring that no segment of the epilepsy community is left behind in the pursuit of scientific advancement.
Impact on Public Health
From a broader public health perspective, the National Plan for Epilepsy offers substantial benefits, translating into a healthier, more equitable society. By improving diagnostic rates and treatment outcomes, the plan is expected to lead to a reduced economic burden on the healthcare system and society at large. Fewer emergency room visits, hospitalizations, and long-term disability claims will free up resources that can be reinvested into prevention and wellness initiatives.
The plan’s commitment to greater public understanding will have a ripple effect, improving community responses to seizures, promoting early intervention, and ultimately fostering a more inclusive society. Educational campaigns will equip first responders, educators, and employers with the knowledge and tools to appropriately support individuals with epilepsy.
Finally, the National Plan directly addresses health equity considerations. By targeting disparities in access to care, research, and education, it aims to ensure that individuals from underserved communities, rural areas, and minority populations receive equitable attention and resources. This focus is critical for achieving a truly national impact, ensuring that the benefits of the plan are distributed fairly across all demographic groups.
Future Outlook and Calls to Action
The publication of "Towards a National Plan for Epilepsy: A Unified Framework for Research, Care, and Awareness" is a monumental achievement, but it is just the beginning. The next steps for the collaborative coalition will involve intensive advocacy efforts to secure federal funding, engage state legislatures, and foster partnerships with private philanthropic organizations. The plan will require sustained commitment from policymakers, healthcare providers, researchers, and the public to translate its ambitious vision into tangible improvements.
Individuals, healthcare providers, and policymakers are urged to engage with the National Plan. Review the detailed consensus priorities at https://www.epilepsy-national-plan.org/consensus-priorities, consider endorsing the initiative, and become advocates for its implementation. The long-term vision is clear: a future where epilepsy is no longer a hidden or misunderstood condition, but one managed with coordinated excellence, leading to improved lives for millions. This National Plan is a testament to the power of unity and a beacon of hope for the entire epilepsy community.
